Correlation Between Cellectar Biosciences and Tenax Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cellectar Biosciences and Tenax Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cellectar Biosciences and Tenax Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cellectar Biosciences and Tenax Therapeutics, you can compare the effects of market volatilities on Cellectar Biosciences and Tenax Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cellectar Biosciences with a short position of Tenax Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cellectar Biosciences and Tenax Therapeutics.

Diversification Opportunities for Cellectar Biosciences and Tenax Therapeutics

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cellectar and Tenax is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Cellectar Biosciences and Tenax Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tenax Therapeutics and Cellectar Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cellectar Biosciences are associated (or correlated) with Tenax Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tenax Therapeutics has no effect on the direction of Cellectar Biosciences i.e., Cellectar Biosciences and Tenax Therapeutics go up and down completely randomly.

Pair Corralation between Cellectar Biosciences and Tenax Therapeutics

Given the investment horizon of 90 days Cellectar Biosciences is expected to generate 0.31 times more return on investment than Tenax Therapeutics. However, Cellectar Biosciences is 3.24 times less risky than Tenax Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Tenax Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  179.00  in Cellectar Biosciences on September 3, 2024 and sell it today you would lose (27.00) from holding Cellectar Biosciences or give up 15.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cellectar Biosciences  vs.  Tenax Therapeutics

 Performance 
       Timeline  
Cellectar Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cellectar Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Tenax Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Tenax Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Tenax Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Cellectar Biosciences and Tenax Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cellectar Biosciences and Tenax Therapeutics

The main advantage of trading using opposite Cellectar Biosciences and Tenax Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cellectar Biosciences position performs unexpectedly, Tenax Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenax Therapeutics will offset losses from the drop in Tenax Therapeutics' long position.
The idea behind Cellectar Biosciences and Tenax Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes